BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Sep 24, 2016; 6(3): 542-547
Published online Sep 24, 2016. doi: 10.5500/wjt.v6.i3.542
Hemodynamic monitoring in heart failure and pulmonary hypertension: From analog tracings to the digital age
Ryan Davey, Amresh Raina
Ryan Davey, Amresh Raina, Cardiovascular Institute, Allegheny General Hospital, Pittsburgh, PA 15212-4772, United States
Author contributions: Both authors contributed equally to this work with regards to article conception, writing and final editing of the manuscript.
Conflict-of-interest statement: Dr. Davey has no relevant financial relationships; Dr. Raina is a consultant for St. Jude’s Medical.
Correspondence to: Amresh Raina, MD, FACC, Associate Director (Pulmonary Hypertension Program, Section of Heart Failure/Transplant/MCS and Pulmonary Hypertension), Assistant Professor of Medicine (Temple University School of Medicine), Cardiovascular Institute, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212-4772, United States. araina@wpahs.org
Telephone: +1-412-3594760 Fax: +1-412-3596544
Received: April 28, 2016
Peer-review started: April 29, 2016
First decision: June 17, 2016
Revised: July 6, 2016
Accepted: July 29, 2016
Article in press: August 1, 2016
Published online: September 24, 2016
Processing time: 147 Days and 17.8 Hours
Core Tip

Core tip: Hemodynamic monitoring forms the cornerstone of heart failure (HF) and pulmonary hypertension diagnosis and management. We review invasive hemodynamic monitors including a number of implantable devices that can allow for ambulatory determination of a variety of intracardiac pressures. These implantable devices have afforded clinicians an opportunity for objective determination of a patient’s volume status and pulmonary pressures. Devices such as the CardioMEMS and thoracic impedance monitors are supported by a body of evidence that show the potential to reduce HF related morbidity. Clinicians should start to familiarize themselves with their use and expect further development and refinement in the future.

Write to the Help Desk